Atorvastatin and Aspirin as Adjuvant Therapy in Patients with SARS-CoV-2 Infection: A structured summary of a study protocol for a randomised controlled trial.

Objectives: To assess the impact of adding statin (atorvastatin) and/or aspirin on clinical deterioration in patients infected with SARS-CoV-2 who require hospitalisation. The safety of these drugs in COVID-19 patients will also be evaluated.Trial Design: This is a single-centre, prospective, four-a...

Descripción completa

Detalles Bibliográficos

Publicado en:	Trials Vol. 21; no. 1; pp. 902 - 903
Autores principales:	Ghati, Nirmal, Roy, Ambuj, Bhatnagar, Sushma, Bhati, Sumit, Bhushan, Sudha, Mahendran, Manjit, Thakur, Abhishek, Tiwari, Pawan, Dwivedi, Tanima, Mani, Kalaivani, Gupta, Ritu, Mohan, Anant, Garg, Rakesh, Saxena, Anita, Guleria, Randeep, Deepti, Siddharthan
Formato:	Journal Article
Publicado:	BioMed Central 10/30/2020
Acceso en línea:	Ver este registro en EBSCOhost